Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Advanced Therapies Week 2022 | Upscaling cell and gene therapy manufacturing

Michael Lehmicke, Senior Director of Science & Industry Affairs, Alliance for Regenerative Medicine, Washington, D.C., talks on the growing interest in developing technologies to improve cell and gene therapy manufacturing, notably in implementing automated processes. Mr Lehmicke emphasizes the importance of standardizing these processes. This interview took place at Advanced Therapies Week 2022.


Michael Lehmicke is the Senior Director of Science & Industry Affairs at Alliance for Regenerative Medicine.